The wealthy owners of Purdue Pharma will be protected in exchange for a multi-billion dollar settlement.
from BBC News - Business https://ift.tt/97VfLgB
Wednesday, May 31, 2023
Home »
England business news
,
latest business news
,
UK business news
» Sackler family can be shielded from opioid lawsuits, court rules
Sackler family can be shielded from opioid lawsuits, court rules
Related Posts:
Google defends Gmail data sharing, gives few details on violationsAlphabet Inc's Google gave details about its policies for third-party Gmail add-ons but stopped short of fully addressing questions from U.S. senators about developers who break its email-scanning rules. from Reuters: Bu… Read More
Caterpillar leans on old playbook to cope with Trump tariffsSix months into the U.S. tariffs on imported aluminum and steel, Caterpillar Inc is finding that one of the best ways it can protect profits is a cost cutting strategy that is more than two years old. from Reuters: Busin… Read More
Asian stocks extend recovery as trade worries take back seatAsian stocks extended gains on Friday after Wall Street's S&P 500 set a new all-time high, while the dollar slipped on views that Beijing's and Washington's fresh exchange of tariffs may be less damaging than initially fe… Read More
Wells Fargo to cut headcount by 5-10 percent in next three yearsWells Fargo & Co said on Thursday it would reduce its headcount by about 5 percent to 10 percent within the next three years as part of a turnaround plan. from Reuters: Business News https://ift.tt/2D… Read More
Fed's Powell between a rock and hard place: Ignore the yield curve or tight job market?Unemployment near a 20-year low screams at the U.S. Federal Reserve to raise interest rates or risk a too-hot economy. The bond market, not far from a state that typically precedes a recession, says not so fast. from Reu… Read More
Millions give less to charity as bills rise
Only a third of 16 to 24-year-olds gave to charity last year, down sharply since the pandemic. from BBC News https://ift.tt/w2UX9LA
0 comments:
Post a Comment